Vaxart Inc (VXRT)
0.8233
+0.06
(+7.97%)
USD |
NASDAQ |
Apr 23, 10:40
Vaxart Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2015 | 94.92% |
| December 31, 2014 | 88.49% |
| September 30, 2014 | -142.9% |
| June 30, 2014 | -15.48% |
| March 31, 2014 | 34.58% |
| December 31, 2013 | 38.38% |
| September 30, 2013 | 13.01% |
| June 30, 2013 | 24.69% |
| March 31, 2013 | 67.24% |
| December 31, 2012 | 31.75% |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | 68.32% |
| June 30, 2011 | 85.34% |
| March 31, 2011 | 93.19% |
| December 31, 2010 | 55.32% |
| September 30, 2010 | 93.17% |
| June 30, 2010 | 87.32% |
| March 31, 2010 | 95.12% |
| December 31, 2009 | 81.05% |
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 |
| Date | Value |
|---|---|
| December 31, 2008 | |
| September 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 | |
| December 31, 2007 | |
| September 30, 2007 | 26.93% |
| June 30, 2007 | |
| March 31, 2007 | 37.94% |
| December 31, 2006 | |
| September 30, 2006 | 21.42% |
| June 30, 2006 | 29.49% |
| March 31, 2006 | 25.97% |
| December 31, 2005 | |
| September 30, 2005 | 39.62% |
| June 30, 2005 | 38.76% |
| March 31, 2005 | 34.57% |
| December 31, 2004 | -765.7% |
| September 30, 2004 | 60.03% |
| June 30, 2004 | 63.60% |
| March 31, 2004 | 48.70% |
| December 31, 2003 | 89.89% |
| September 30, 2003 | 49.28% |
| June 30, 2003 | 41.96% |
| March 31, 2003 | 32.31% |
| December 31, 2002 | 51.49% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Novavax Inc | 38.84% |
| aTyr Pharma Inc | -- |
| Allogene Therapeutics Inc | -- |
| AIM ImmunoTech Inc | 81.54% |
| Protalix BioTherapeutics Inc | 15.54% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -99.42% |
| Return on Assets | -68.29% |
| Return on Invested Capital | -99.42% |
| Profit Margin (Quarterly) | -262.3% |
| Operating Margin (Quarterly) | -255.1% |
| Return on Net Operating Assets | -155.9% |